Pharmafit Provence
OLIGOSOL Magnesium S oral in ampoule 28Amp/2ml

EA Pharma Laboratoire des Granions

OLIGOSOL Magnesium S oral in ampoule 28Amp/2ml

CIP / EAN code: 3400937546850

Product information from VIDAL.

Read the product information

Product information

Find indications, dosage and precautions in the sections below.

Automatic English translation of the French VIDAL document. Original numerical values and units are retained, including decimal commas.

VIDAL
Medicines
SmPC of 10/08/2021

MAGNESIUM OLIGOSOL, oral solution in ampoule


Forms and presentations

Oral solution.
Ampoule with two self-breaking tips of 2 ml. Box of 28.


Composition

For one ampoule of 2 ml:

Magnesium gluconate: 1,781 mg
(Corresponding quantity of magnesium: 0,1044 mg)

Excipient with known effect: glucose (100 mg in one ampoule of 2 ml).


Excipients:

Glucose monohydrate and purified water.



Indications

Used as a terrain modifier, in particular during states of neurovegetative dystonia and states grouped under the term spasmophilia.



Dosage and administration

Dosage

FOR ADULTS ONLY.

1 to 3 ampoules per day.

The ampoules are to be taken:

  • preferably in the morning on an empty stomach,
  • possibly 15 minutes before a meal or in the evening at bedtime.

Method of administration

Oral use

Sublingual administration is recommended: hold the contents of the ampoule under the tongue for 1 to 2 minutes before swallowing.



Contraindications

Hypersensitivity to the active substance or to any of the excipients listed in section Composition.



Warnings and precautions

This medicine contains glucose. Patients with glucose-galactose malabsorption syndrome (a rare hereditary disease) must not take this medicine.

Treatment with this trace mineral element does not replace any specific treatment that may be needed.



Interactions

The data available to date do not suggest the existence of clinically significant interactions.



Fertility, pregnancy and breastfeeding

No adverse effects are expected with these doses of magnesium during pregnancy and breastfeeding.



Driving and using machines

MAGNESIUM OLIGOSOL, oral solution in ampoule has no effect on the ability to drive vehicles or use machines.



Adverse effects

Reporting of suspected adverse reactions

Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system: National Agency for the Safety of Medicines and Health Products (ANSM) and the network of Regional Pharmacovigilance Centres - Website: https://signalement.social-sante.gouv.fr.



Overdose

No cases of overdose have been reported.



Pharmacodynamics

Pharmacotherapeutic class: OLIGOTHERAPY (V: various)

Trace mineral element.



Shelf life

5 years.



Special storage precautions

Store at a temperature not exceeding 25 °C.



SPECIAL PRECAUTIONS FOR DISPOSAL AND OTHER HANDLING

No special requirements.



Prescription, supply and reimbursement

Marketing authorisation (AMM)
CIP 3400937546850 (28 amp/2 mL).
Not reimbursed by Social Security.
 
Marketing authorisation holder: Labcatal, 1198 avenue Docteur Maurice Donat, Zac du Fond de l'Orme, 06250 Mougins.

GRANIONS EA-PHARMA Laboratory
Le Parador II
5, allée Crovetto-Frères. 98000 Monaco
Tel: 00 377 92 05 76 30

Source: VIDAL · Updated on 11/11/2026. This information does not replace advice from a healthcare professional.